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The patient was a 67-year-old female diagnosed with dilated cardiomyopathy. She had
chronic atrial ﬁbrillation (AF) with bradycardia and low left ventricular function (left
ventricular ejection fraction (LVEF) 40%). She was admitted for congestive heart failure. She
remained New York Heart Association (NYHA) functional class III due to AF bradycardia.
Pacemaker implantation was necessary for treatment of heart failure and administration of
dose intensive -blockers. As she had normal His-Purkinje activation, we examined the
optimal pacing sites. Hemodynamics of His-bundle pacing and biventricular pacing were
compared. Pulmonary capillary wedge pressure (PCWP) was signiﬁcantly lower on His-
bundle pacing than right ventricular (RV) apical pacing and biventricular pacing (13mmHg,
19mmHg, and 19mmHg, respectively) with an almost equal cardiac index. Based on the
examination we implanted a permanent pacemaker for Direct His-bundle pacing (DHBP).
After the DHBP implantation, the LVEF immediately improved from 40% to 55%, and BNP
level decreased from 422 pg/ml to 42 pg/ml. The number of premature ventricular complex
(PVC) was decreased, and non sustained ventricular tachycardia (NSVT) disappeared. Pacing
threshold for His-bundle pacing has remained at the same level. His-bundle pacing has been
maintained during 27 months and her long-term DHBP can improve cardiac function and the
NYHA functional class.
(J Arrhythmia 2006; 22: 245–250)
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Introduction
Several clinical trials have evaluated that biven-
tricular pacing can improve intraventricular conduc-
tion delays (IVCD) in heart failure patients. Biven-
tricular pacing has been adapted for therapy-resistant
heart failure patients because intraventricular con-
duction delay would deteriorate not only dyssyn-
chronous left ventricular contraction but also ven-
tricular performance. Recently Direct His-bundle
pacing (DHBP) has been applied for heart failure
patients with normal His-Purkinje activation instead
of conventional apical pacing. Even though DHBP
has still some technical problems of implantation,
Address for correspondance: Fumiaki Mori MD, Department of Cardiology, Tokyo Medical Women’s University, 8-1 Kawadacho
Shinjuku-ku, Tokyo 162-8666, Japan. Tel: 03-3353-8111 Fax: 03-3341-0472
Received 12, September, 2006: accepted in ﬁnal form 1, December, 2006.
245
Sashida Y Direct His-bundle pacing in dilated cardiomopathy
Case Report
DHBP is able to provide improved non-artiﬁcial
synchronous ventricular depolarization and prevent
reduction of cardiac function compared to apical
pacing. We report a case of dilated cardiomyopathy
with bradycardia, which had been clinically im-
proved by permanent DHBP implantation for more
than 2 years.
Case Report
In March 2004, a 67-year-old female with dilated
cardiomyopathy was admitted to our hospital from
another hospital for treatment of congestive heart
failure (New York Heart Association (NYHA) func-
tional class III) and non-sustained ventricular tachy-
cardia (NSVT). Her cardiac catheter examination
in her previous hospital showed a left ventricular
ejection fraction (LVEF) of 21% and normal coro-
nary arteries. In physical examinations, her blood
pressure was 90/40mmHg, and pulse rate was 56
beats/min with an irregular rhythm. She showed
neither murmur nor rales, and she did not have leg
edema. Cardiothoracic ratio (CTR) was 62% on
chest radiography, and the ECG showed atrial
ﬁbrillation without IVCD (QRS ¼ 89msec, Figure
1A). Left ventricular end-diastolic dimension
(LVDd) was 52mm and left ventricular wall motion
revealed diﬀuse severe hypokinesis (LVEF, 40%)
with mild mitral regurgitation on echocardiography.
Biochemistry examinations were not remarkable
other than her serum B-type natriuretic peptide
(BNP) level of 423 pg/ml. Holter electrocardiogra-
phy showed atrial ﬁbrillation with beadycardia
(mean heart rate, 51 beats/min), and frequent pre-
mature ventricular complexes (PVCs) and NSVT
(PVCs, 2116 beats/day; NSVTs, 5 times/day and
maximum length 5 beats).
After starting amiodarone administration for
NSVT, bradycardia deteriorated (mean heart rate,
41 beats/min). Pacemaker implantation and admin-
istration of dose intensive -blockers (carvedilol
10mg per day) was necessary for treatment of heart
failure. As she had normal His-Purkinje conduction,
we examined the comparative hemodynamics for
right ventricular (RV) apical pacing, His-bundle
pacing, and biventricular pacing (Table 1). For
biventricular pacing, a deﬂectable catheter was
positioned in the left ventricular lateral wall and
stimulated with a RV apical temporary pacing
catheter. The pulmonary capillary wedge pressure
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Figure 1 Surface 12-lead electro-
cardiogram comparing native con-
duction and DHBP.
QRS and T-wave of DHBP (B) are in
concordance with that of native con-
duction (A).
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was signiﬁcantly lower on His-bundle pacing than
RV and biventricular pacing (13mmHg, 19mmHg,
and 19mmHg, respectively) with a nearly equal
cardiac index.
Based on the examination, we implanted a
permanent DHBP-type pacemaker. The surgery took
3 hours and 10 minutes. First, a His-bundle mapping
catheter was introduced via the right femoral vein. A
bipolar screw-in lead (Thin Line II Sterox, model
No. 430-35S, Intermedics) was introduced via the
right subclavian vein and advanced to the atrioven-
tricular septum. Iterative adjustments to the ‘‘J’’-
shaped stylet were required because of patient’s
anatomy. A lead was required to achieve optimal
positioning near the mapping catheter and adjusted
to obtain the largest His potential using a modiﬁed
‘‘J’’-shaped stylet. The lead could capture the His
bundle directly at reasonable low pacing out put
(Figure 2). Another lead (CapSureFix NOVUS, mod-
el No. 5068, Medtronic) was positioned in the RV
apical septum for back-up pacing (acute pacing
threshold was 0.9 V at 0.5msec pulse width, R-wave
sensing was 10.2mV). The lead for His-bundle
pacing was connected to the atrial port, and another
lead was connected to the ventricular port. The
pacemaker was set at AAI mode and a ﬁxed rate of
70 beats/min. Acute His-bundle pacing threshold
was 3.2V at 0.5msec pulse width, and sensed
potential (R-wave sensing) was 4.2mV. Atrial far-
ﬁeld potentials were never observed. QRS complex
of DHBP was in concordance with that of native
conduction (Figure 1).
100% His-bundle pacing has been maintained
during 27 months after the pacemaker implantation.
Drug therapy including intensive -blockers has
been continued at the same dose. In April 2004, her
echocardiograms showed a remarkable improvement
of LVEF from 40% to 55%, and her mild mitral
regurgitation disappeared, which has continued to
the present. The CTR decreased from 62% to 56%
in about one month (Figure 3). BNP immediately
decreased from 423 pg/ml to 237 pg/ml in a week
after DHBP implantation, and afterward gradually
decreased to 42 pg/ml (Figure 4). The number of
PVCs decreased from 2116 beats/day to 66 beats/
day and the NSVT has disappeared. NYHA func-
tional class is improving from class III to class I at
present. Chronic His-bundle pacing threshold after 2
years was 3.2 V at a 0.5msec pulse width, and it
remains unchanged.
Table 1 Hemodynamic data at diﬀerent pacing sites.
Pacing site control RV Bi-Vent His-bundle
HR 54 70 70 70
PA (sys/dia) 39/11 39/17 41/17 42/16
PCWP (m) 10 19 19 13
CI 1.83 2.04 1.85 2.09
BP (sys/dia) 135/65 139/73 142/64 146/77
HR = heart rate (/min)
PA = pulmonary artery pressure (systolic/diastolic, mmHg)
PCWP = pulmonary capillary wedge pressure (mean, mmHg)
CI = cardiac index (L/min/m2)
BP = blood pressure (systolic/diastolic, mmHg)
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Figure 2 Intracardiac electrograms from His-bandle mapping catheter (HBED, distal and HBEP,
proximal) and pacemaker lead for DHBP (PM-L).
(A) is intrinsically conducted, and (B) is His-bundle paced. HV interval (H-V) in native conduction is 70msec.
Equivalence in His-ventricular (H-V) and pace-ventricular (P-H) activation intervals provides evidence of
successful DHBP.
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Discussion
Antibradicardia pacemaker therapy is considered
to be a somewhat well-established method. Many
studies have actually shown the eﬀectiveness of
physiologic pacing therapy in the past. The DANISH
trial1) proved the beneﬁcial eﬀect of physiologic
pacing. The trial showed that atrial pacing was
associated with a signiﬁcantly higher survival, less
atrial ﬁbrillation and heart failure than ventricular
pacing. However, CTOPP,2) MOST,3) PACE,4) and
UKPACE5) reported that diﬀerences between phys-
iologic pacing and ventricular pacing were not
signiﬁcant in the rates of heart failure and survival
except for atrial ﬁbrillation. The DAVID trial6)
reported that dual-chamber pacing compared with
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Figure 3 Radiographic images showing reduction in heart size, before (A) and after sustained DHBP in about one month (B),
(C).
The CTR decreased from 62% to 56% in about one month.
2004.3 2005.3 2006.3
2004.3 2005.3 2006.3
LVDd(mm)
LVDs(mm)
LVEF (%)
35
45
55
100
500
BNP
(pg/ml)(A)
(B)
Figure 4 Changes of serum BNP level (A)
and echocardiographic data (B).
BNP immediately decreased from 423 pg/ml to
237 pg/ml in a week after DHBP implantation,
and afterward gradually decreased to 42 pg/ml.
Echocardiographic data showed remarkable im-
provement of LVEF from 40% to 55%. Dotted
line is the day of DHBP implantation.
LVDd = Left ventricular diastolic dimension
LVDs = Left ventricular systolic dimension
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ventricular backup pacing was associated with an
increase of the combined end point of death or
hospitalization for heart failure for patients with both
standard indications for ICD therapy and a LVEF of
less than 40%. Sweeny et al.7) reported that a 10%
increase of cumulative ventricular pacing was cor-
related with a 54% increase in risk of heart failure
hospitalization even though AV synchrony was
preserved. These studies suggest that right ventric-
ular apical pacing produces a left ventricular elec-
trical activation sequence resembling left bundle-
branch block, and consequently can induce heart
failure.
On the other hand, recent studies showed that
biventricular pacing therapy is eﬃcient for severe
heart failure patients with IVCD.8–10) Approximately
15% to 30% of advanced heart failure patients have
been associated with IVCD. The biventricular pacing
strategy is based on the fact that most patients with
IVCD have a dyssynchronous left ventricular con-
traction, which results in a reduction in ventricular
performance. It remains unclear whether biventric-
ular pacing therapy provides the most beneﬁt for
non-IVCD heart failure patients.
The patient described in this study had a severe
ventricular dysfunction (LVEF, 40%) with dilated
cardiomyopathy and chronic atrial ﬁbrillation, and
demonstrated NYHA functional class III. Though
she was treated with maximal tolerated medical
therapy for heart failure, including agiotensin II type
1 receptor antagonists and -blockers, she remained
NYHA functional class III and her bradicardia
worsened. Because she had a narrow QRS complex,
we examined her hemodynamic function during
His-bundle pacing as well as biventricular pacing.
His-bundle pacing increased her cardiac index and
decreased her pulmonary capillary wedge pressure
more eﬀectively than biventricular pacing. We
thought that His-bundle pacing was favorable for
its acute hemodynamic eﬀects, and she underwent
a permanent DHBP implantation. Her permanent
DHBP resulted in dramatic improvements in LVEF,
BNP and NYHA functional class, and improved
levels have been maintained during 27 months after
pacemaker implantation.
Few studies have shown that DHBP improved
cardiac function for dilated cardiomyopathy with
atrial ﬁbrillation.11) This case suggests that a perma-
nent DHBP can achieve sustainable improvements
of cardiac function and NYHA class. These eﬀects
could be derived from the regularity of the pace-
maker rate and maintaining physiologic contraction
without ventricular dyssynchrony. This agrees with a
recent study.12) On the one hand, pacing therapy
enabled us to continue administration -blockers. It
is not clear if the documented beneﬁt can be related,
at lease in part, to continued administration of -
blockers rather than to pacing modality. In any case,
DHBP can provide the maximum therapeutic beneﬁt
in bradycardia patients with chronic atrial ﬁbrilla-
tion, dilated cardiomyopathy, and LV dysfunction
with preserved ventricular activation. DHBP would
be one of the most eﬀective methods, especially for
chronic heart failure patients without IVCD who
have diﬃculty taking -blockers because of brady-
cardia.
His-bundle pacing may be an appropriate pacing
site for antibradicardia pacemaker therapy. There is a
problem with regard to the diﬃculty of placing a
pacing lead at the His-bundle. It is useful to place a
standard multipolar mapping catheter as a guide at
the His bundle, and this enables the placement of
a screw-in pacing lead to be embedded in the
membranous septum or on near the His bundle.
Although acute and chronic pacing thresholds for
His-bundle pacing were relatively higher than for
RV pacing in the present case, the pacing thresh-
olds remained clinically acceptable. However, it is
capable of appearing with IVCD, with deterioration
of the threshold according to disease progression,
and sometimes happens the His-bundle pacing lead
is dislocated. We positioned another lead to the
RV septum for back-up pacing, as we considered
options.
Permanent DHBP can provide more beneﬁt for
both heart failure patients without IVCD and patients
with indications for antibradicardia pacing therapy.
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